CNA Explains: What you need to know about the XBB COVID-19 ...
CNA - 11 Oct 2022How widespread is the XBB variant globally and in Singapore? Are you protected from it if you are vaccinated and how effective will the bivalent COVID-19 ...
XBB variant
How widespread is the XBB variant globally and in Singapore? Are you protected from it if you are vaccinated and how effective will the bivalent COVID-19 ...
MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta
The Straits Times - 22 Nov 2024MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta ...
What COVID-19 variants are going around in April 2025?
Nebraska Medicine Omaha, NE - 14 Apr 2025What COVID-19 variants are going around in April 2025? ...
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant
Nature - 13 Mar 2025Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant ...
Symptoms and Preventions of the COVID Omicron-XBB Variant
Siloam Hospitals - 21 Aug 2024Symptoms and Preventions of the COVID Omicron-XBB Variant ...
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design
Duke University School of Medicine - 04 Sep 2024Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design ...
S. Korean health authorities reject baseless 'Omicron surge' warning
Fact Check AFP - 24 Jan 2025S. Korean health authorities reject baseless 'Omicron surge' warning ...
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants
Frontiers - 16 Feb 2025XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants ...
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform - eClinicalMedicine
The Lancet - 07 Dec 2024Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform - eClinicalMedicine ...
‘Kraken’ coronavirus subvariant: Why it is causing concern
The Straits Times - 25 Nov 2024‘Kraken’ coronavirus subvariant: Why it is causing concern ...
Corrections regarding XBB wave in Singapore
Factually - 14 Oct 2022Corrections regarding XBB wave in Singapore ...
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nature - 09 Jan 2025Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections ...
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells
Frontiers - 11 Mar 2025The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells ...
What to know about XBB and other Omicron subvariants
The Straits Times - 25 Nov 2024What to know about XBB and other Omicron subvariants ...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines
Nature - 20 Nov 2024Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines ...
Here’s what we know about the new Covid-19 variant ‘Eris’
The Straits Times - 15 Nov 2024Here’s what we know about the new Covid-19 variant ‘Eris’ ...
Neutralizing antibody responses to three XBB protein vaccines in older adults
Nature - 03 Feb 2025Neutralizing antibody responses to three XBB protein vaccines in older adults ...
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
Nature - 27 Jan 2025Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages ...
Covid-19 variant maintains threat, says WHO
The Straits Times - 12 Nov 2024Covid-19 variant maintains threat, says WHO ...
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials
Nature - 30 Dec 2024Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials ...